Avise Analytics is the fastest growing equity research firm that authors institutional quality equity research reports, with special focus on Nano-Cap and Micro-Cap companies that are undervalued and lacks adequate coverage.
Our team of highly experienced analysts provides a wide range of tailored services in the field of equity, investment and financial research and investor relations to our diversified client base around the world.
Our free mobile app gives you real-time notifications on publication of short company stories for compelling investment ideas so that you never miss an opportunity!
As a step to effectively handle your research team’s workload as a business partner, our free mobile (and tablet friendly) application, also offer you a complete accessibility in tracking your project progress and billing and payment status at the tip of your finger any time.
Download the app for free now to explore our talent pool and feel the difference in outsourcing your work to us.
We pride ourselves in constantly delivering high-quality and scalable equity, investment and credit research solutions to our diversified client base across 9 countries. A snapshot of our key experience in past 3 years includes:
SunHydrogen, Inc. (OTCPK: HYSR) formerly known as HyperSolar Inc, is a pioneer in the production of nanoparticle systems...07 May, 2021No comment
The Company is developing a pipeline of candidates focused on small molecules and biologics that can treat central nervo...05 May, 2021No comment
Evelo Biosciences, Inc. (NASDAQ: EVLO) is focused on developing innovative oral biologics that target cells in the intes...03 May, 2021No comment
Humanigen, Inc. (NASDAQ: HGEN) is a clinical-stage biopharmaceutical Company that is focused on creating a portfolio of ...30 April, 2021No comment
Livent Corporation (NYSE: LTHM) is a premier pure-play lithium technology company that delivers cutting-edge polymers an...29 April, 2021No comment
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering ...28 April, 2021No comment
Covid-19 has bought many biotech companies into the limelight, all promising a possible solution to the pandemic that ha...27 April, 2021No comment
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is a clinical-stage biopharmaceutical company that is developing innovative p...26 April, 2021No comment
Globalstar, Inc. (NYSE: GSAT), a premier mobile satellite services company, announced that its subsidiary Globalstar, In...16 April, 2021No comment
CytoKinetics, Inc. (NASDAQ: CYTK), a late-stage biopharmaceutical company, is developing therapeutics for the treatment ...15 April, 2021No comment
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is focused on developing innovative small molecule drugs that target hematolo...14 April, 2021No comment
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering ...13 April, 2021No comment
Innodata, Inc. (NASDAQ: INOD) is a leading global data engineering company that is using a combination of artificial int...12 April, 2021No comment
Ontrak Inc (NASDAQ: OTRK), a virtual provider of AI-powered Telehealth solutions announced the signing of an updated con...09 April, 2021No comment
Avise Analytics is a professionally managed organization and understood job scopes & requirements very well. The report and analysis generated meet my expectations and will not hesitate to recommend others.
Delivered a high-quality set of documents that exceeded my expectations. Keep up the good work!!
Great team. We ramped up our coverage universe quickly due to their help. I highly recommend them!
High quality equity research provider that we now use for regular work
Excellent communication skills and a high commitment to client satisfaction.
Instrumental in helping us complete the research in such a tight timeline!
I have found Avise Analytics to be a great, cost-effective solution to providing both simple and complex finance-related articles for various blogs and newsletters. They are detailed oriented, consciences, respond well to direction, prompt and really know the finance industry.